EA
DGX icon

Edge Advisors’s Quest Diagnostics DGX Stock Holding History

Edge Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$0 Hold
6
– – ﹤0.01% 843
2018
Q1 		$0 Hold
6
– – ﹤0.01% 882
2017
Q4 		$0 Buy
6
+5
+500% +$474 ﹤0.01% 921
2017
Q3 		$0 Hold
1
– – ﹤0.01% 898
2017
Q2 		$0 Hold
1
– – ﹤0.01% 945
2017
Q1 		$0 Hold
1
– – ﹤0.01% 946
2016
Q4 		$0 Buy
+1
New +$86 ﹤0.01% 842

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Edge Advisors's DGX Position: Q2 2018 in Review

Edge Advisors held its Quest Diagnostics (DGX) position steady in Q2 2018 at 6 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #843.

Edge Advisors first reported a position in DGX in Q4 2016 and has held it in 7 quarters since. 662 funds tracked by Wall St. Rank hold DGX as of Q2 2018.

  • Edge Advisors held 6 shares of Quest Diagnostics worth $0 as of Q2 2018.
  • Edge Advisors left its Quest Diagnostics share count unchanged in Q2 2018.
  • Quest Diagnostics made up ﹤0.01% of Edge Advisors's portfolio in Q2 2018, its #843 holding.
  • Edge Advisors first reported a position in Quest Diagnostics in Q4 2016 and has held it in 7 quarters since.
  • 662 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.